Institution
Kempenhaeghe
- 8running trials
- 9closed trials
- 1,440publications (OpenAlex)
Running trials
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Recruiting
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach
Enrolling by invitation
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy5 recruiting
- Narcolepsy3 recruiting
Closed trials
Completed
REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome
Completed
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
Registry name variants (3)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Kempenhaeghe
Heeze, 5591BL VE
12 trials
Kempenhaeghe - PPDS
Heeze, North Brabant 5591 VE
5 trials
Kempenhaeghe - Academisch Centrum voor Epilepsie
Heeze, Netherlands
1 trial
Institution data: ROR 03bbe8e53 (CC0-1.0)Updated 3 Nov 2026